November 2, 2010
Viamet Pharmaceuticals, Dow AgroSciences to Collaborate on Development of Improved Crop Protection Products
Research to focus on novel agricultural chemicals with new modes of action MIDLAND, MICHIGAN and MORRISVILLE, NORTH CAROLINA – Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE:…
September 20, 2010
Boston Scientific to Acquire Asthmatx
Asthmatx offers first FDA-approved non-drug procedure for the treatment of severe asthma NATICK, Mass. and SUNNYVALE, Calif., (PRNewswire-FirstCall) – Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive…
August 24, 2010
Inc. Magazine Names Clinipace Worldwide to the Inc. 500 Annual List of America’s Fastest-Growing Private Companies
Exclusive Ranking Demonstrates Market Adoption of Technology-Amplified Service Delivery and a True Testament to Employee Hard Work and Customer Loyalty (BusinessWire) – Clinipace Worldwide, a global full-service clinical research organization (CRO),…
February 23, 2010
Viamet, Novartis Fund Targeting Metalloenzymes in $200M Deal
By Catherine Hollingsworth, Staff Writer (BioWorld Today) – Viamet Pharmaceuticals Inc. signed a deal worth more than $200 million with the Novartis Option Fund to discover and develop metalloenzyme inhibitors…
January 4, 2010
HistoSonics, Inc. Announces Series A Financing
Ann Arbor, MI – HistoSonics, Inc. today announced it has secured $11 million in a Series A financing led by Venture Investors of Ann Arbor, Michigan and Madison, Wisconsin. Venture Investors worked closely with Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners, and TGap Ventures to assemble an outstanding investment syndicate.